| 000 | 01054n m a2200241 4500 | ||
|---|---|---|---|
| 003 | H12O | ||
| 005 | 20180417112631.0 | ||
| 008 | 130622s2014 xxx||||| |||| 00| 0 eng d | ||
| 040 | _cH12O | ||
| 100 |
_aGómez Valbuena, Isabel _91927 _eFarmacia |
||
| 100 |
_aAlioto, Daniel _91928 _eFarmacia |
||
| 100 |
_aSerrano Garrote, Olga _91918 _eFarmacia |
||
| 100 |
_aFerrari Piquero, José Miguel _9872 _eFarmacia |
||
| 245 | 0 | 0 |
_aEnzalutamide: new alternative for treatment of prostate cancer metastatic _h[artículo] |
| 260 |
_bEuropean Journal of Clinical Pharmacy, _c2014 |
||
| 300 | _a16(5):353-356. | ||
| 337 | _aJOUR | ||
| 500 | _aFormato Vancouver Gómez Valbuena I, Alioto D, Serrano Garrote O, Ferrari Piquero JM. Enzalutamide: new alternative for treatment of prostate cancer metastatic. Eur J Clin Pharm. 2014;16(5):353-6. | ||
| 501 | _aContiene 12 referencias, 1 figura y 1 tabla. | ||
| 710 |
_9320 _aServicio de Farmacia Hospitalaria |
||
| 856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/7/pc7908.pdf _ySolicitar documento |
||
| 942 |
_n0 _2ddc _cART |
||
| 999 |
_c7908 _d7908 |
||